» Articles » PMID: 20967331

High-throughput 3D Spheroid Culture and Drug Testing Using a 384 Hanging Drop Array

Overview
Journal Analyst
Specialty Chemistry
Date 2010 Oct 23
PMID 20967331
Citations 357
Authors
Affiliations
Soon will be listed here.
Abstract

Culture of cells as three-dimensional (3D) aggregates can enhance in vitro tests for basic biological research as well as for therapeutics development. Such 3D culture models, however, are often more complicated, cumbersome, and expensive than two-dimensional (2D) cultures. This paper describes a 384-well format hanging drop culture plate that makes spheroid formation, culture, and subsequent drug testing on the obtained 3D cellular constructs as straightforward to perform and adapt to existing high-throughput screening (HTS) instruments as conventional 2D cultures. Using this platform, we show that drugs with different modes of action produce distinct responses in the physiological 3D cell spheroids compared to conventional 2D cell monolayers. Specifically, the anticancer drug 5-fluorouracil (5-FU) has higher anti-proliferative effects on 2D cultures whereas the hypoxia activated drug commonly referred to as tirapazamine (TPZ) are more effective against 3D cultures. The multiplexed 3D hanging drop culture and testing plate provides an efficient way to obtain biological insights that are often lost in 2D platforms.

Citing Articles

Imaging cell spheroid clusters: An MRI protocol for non-invasive standardized characterization.

Wissmann R, Martirosian P, Danalache M, Grozinger G, Schick F, Elser S Heliyon. 2025; 11(2):e41803.

PMID: 39897913 PMC: 11787676. DOI: 10.1016/j.heliyon.2025.e41803.


Synergistic Approach of High-Precision 3D Printing and Low Cell Adhesion for Enhanced Self-Assembled Spheroid Formation.

Lu C, Jin A, Gao C, Qiao H, Liu H, Zhang Y Biosensors (Basel). 2025; 15(1).

PMID: 39852058 PMC: 11764235. DOI: 10.3390/bios15010007.


High-throughput non-homogenous 3D polycaprolactone scaffold for cancer cell and cancer-associated fibroblast mini-tumors to evaluate drug treatment response.

Malakpour-Permlid A, Rodriguez M, Untracht G, Andersen P, Oredsson S, Boisen A Toxicol Rep. 2025; 14:101863.

PMID: 39758801 PMC: 11699757. DOI: 10.1016/j.toxrep.2024.101863.


Sound innovations for biofabrication and tissue engineering.

Wu M, Ma Z, Tian Z, Rich J, He X, Xia J Microsyst Nanoeng. 2024; 10(1):170.

PMID: 39562793 PMC: 11577104. DOI: 10.1038/s41378-024-00759-5.


An automated high-content screening and assay platform for the analysis of spheroids at subcellular resolution.

Mysior M, Simpson J PLoS One. 2024; 19(11):e0311963.

PMID: 39531451 PMC: 11556727. DOI: 10.1371/journal.pone.0311963.


References
1.
Fukuda J, Khademhosseini A, Yeo Y, Yang X, Yeh J, Eng G . Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials. 2006; 27(30):5259-67. DOI: 10.1016/j.biomaterials.2006.05.044. View

2.
Sakai Y, Nakazawa K . Technique for the control of spheroid diameter using microfabricated chips. Acta Biomater. 2007; 3(6):1033-40. DOI: 10.1016/j.actbio.2007.06.004. View

3.
Torisawa Y, Takagi A, Nashimoto Y, Yasukawa T, Shiku H, Matsue T . A multicellular spheroid array to realize spheroid formation, culture, and viability assay on a chip. Biomaterials. 2006; 28(3):559-66. DOI: 10.1016/j.biomaterials.2006.08.054. View

4.
Kunz-Schughart L, Freyer J, Hofstaedter F, Ebner R . The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen. 2004; 9(4):273-85. DOI: 10.1177/1087057104265040. View

5.
Friedrich J, Seidel C, Ebner R, Kunz-Schughart L . Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009; 4(3):309-24. DOI: 10.1038/nprot.2008.226. View